ATC Group: A11HA02 Pyridoxine (vit B6)

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A11HA02 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A11 Vitamins
3 A11H Other plain vitamin preparations
4 A11HA Other plain vitamin preparations
5 A11HA02 Pyridoxine (vit B6)

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.16 g
PAREN - Parenteral 0.16 g

Active ingredients in A11HA02

Active Ingredient Description
Pyridoxine

Pyridoxine hydrochloride is Vitamin B6. It is converted to pyridoxal phosphate which is the co-enzyme for a variety of metabolic transformations. It is essential for human nutrition.

Medicines in this ATC group

Brazil (BR)

Estonia (EE)

France (FR)

Germany (DE)

Hong Kong (HK)

Lithuania (LT)

Poland (PL)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.